Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Richard W. Declue"'
Autor:
Mugdha Gokhale, Rebekah Yu, Matthew Monberg, Cumhur Tekin, Lei Chen, Richard W. DeClue, Keith Knapp, Lincy S. Lal
Publikováno v:
Cancer Treatment and Research Communications, Vol 36, Iss , Pp 100726- (2023)
Objective: Patients with persistent, recurrent, or metastatic cervical cancer have poor prognosis. While recent advances have expanded treatment options, real-world data on treatment patterns and outcomes in this population are lacking. Methods: This
Externí odkaz:
https://doaj.org/article/0fabcbdab59a4416b286cc2fcda405e0
Publikováno v:
Future Oncology.
Aim: Real-world data on treatment patterns and outcomes of advanced ovarian cancer (OC) patients since bevacizumab approval in first-line (1L) OC treatment were assessed. Materials & methods: In this descriptive retrospective study using the ConcertA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c6100fb22f21863ebfa08b184284dfe
https://doi.org/10.2217/fon-2022-0955
https://doi.org/10.2217/fon-2022-0955
Autor:
Richard W DeClue, Kevin Chin, Lisa Herms, Vivek Pawar, Xinke Zhang, Elizabeth T. Masters, Mo Yang, Vamsidhar Velcheti, Mary Ruisi
Publikováno v:
Immunotherapy. 13:1521-1533
Aim: We report real-world treatment patterns and outcomes in patients with PD-L1+ non-small-cell lung cancer (NSCLC). Methods: This retrospective, observational study using the ConcertAI Oncology Dataset (Symphony AI, CA, USA), included patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35361282b8ee7460345a3f00a86a985a
https://doi.org/10.2217/imt-2021-0145
https://doi.org/10.2217/imt-2021-0145
Autor:
Brandon T. Suehs, Eleanor O. Caplan, Richard W DeClue, Karina Raimundo, Tiffany Fair Shaffer, Anisha M. Patel, Marina Sehman, Daniel Cornett
Publikováno v:
Journal of Comparative Effectiveness Research. 10:1121-1131
Aim: Examine real-world characteristics, treatment patterns, and outcomes among treated persons with hemophilia A (PwHA) stratified by age. Patients & methods: This study utilized US claims data from 1 January 2007–31 July 2018 from the Humana Rese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bd96831fbbaafb5db4ab7d64f901d7d
https://doi.org/10.2217/cer-2021-0109
https://doi.org/10.2217/cer-2021-0109
Publikováno v:
Future Oncology. 17:1879-1887
Background: There is limited real-world information on use of tumor mutational burden (TMB) testing and characteristics of patients receiving it. Materials & methods: Patients ≥18 years old and diagnosed with advanced solid tumors between 1 January
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::263ebd166b06b0329e90d9d65bbb1bc5
https://doi.org/10.2217/fon-2020-1005
https://doi.org/10.2217/fon-2020-1005
Autor:
Andrew Renda, Sarika Ogale, Bryan A. Loy, Richard W DeClue, Todd Michael, Dana Drzayich Antol, Stephen Stemkowski, Adrianne Waldman Casebeer, Marina Sehman
Publikováno v:
The American Journal of Managed Care. 26:e191-e197
Objectives The goal of this study was to establish a claims-based mechanism for identifying patients with metastatic non-small cell lung cancer (mNSCLC) and high levels of patient-reported cancer-related symptoms who could benefit from engagement wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c584e69a33062e12e5700f685f8b4f2d
https://doi.org/10.37765/ajmc.2020.43495
https://doi.org/10.37765/ajmc.2020.43495
Autor:
Neil A. Accortt, Ran Jin, Kashyap Patel, Whitney C Rhodes, Darcie Sandschafer, Debra Wertz, Richard W DeClue
Publikováno v:
Future oncology (London, England). 17(36)
Aim: Evaluated real world use of bevacizumab-awwb (MVASI®), a bevacizumab biosimilar, for treating metastatic colorectal cancer (mCRC). Materials & methods: Adult mCRC patients who received bevacizumab-awwb during the first year after market availab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5478d028959b2bcb1345e01e7f7123e
https://pubmed.ncbi.nlm.nih.gov/34698523
https://pubmed.ncbi.nlm.nih.gov/34698523
Publikováno v:
Journal of comparative effectiveness research. 10(10)
Aim & methods: This real-world study examined the association of tumor mutational burden (TMB) with clinical and healthcare utilization in adults diagnosed with advanced solid tumor 1 January 2015– 31 January 2019. Results: There were 170 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5903c535a47aba26dd537705fe32a7c2
https://pubmed.ncbi.nlm.nih.gov/34047199
https://pubmed.ncbi.nlm.nih.gov/34047199
Publikováno v:
Value in Health. 24:S24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98b9a9a5a9ef677a10968e26160b2d26
https://doi.org/10.1016/j.jval.2021.04.125
https://doi.org/10.1016/j.jval.2021.04.125
Autor:
Adrianne Waldman Casebeer, Yong Li, Richard W DeClue, Chun Lan Chang, Nancy M. Albert, Dana Drzayich Antol, Stephen Stemkowski
Publikováno v:
Advances in Therapy. 34:2345-2359
Factors associated with mortality for patients with heart failure and reduced ejection fraction (HFrEF) are known; however, the association between initial pharmacotherapy (IPT) and mortality is unclear in real-world settings. Using a retrospective d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82c502b862de50c9460c5afd670c52a7
https://doi.org/10.1007/s12325-017-0618-4
https://doi.org/10.1007/s12325-017-0618-4